Skip to content Skip to footer

Rare Disease Forum by Genetidoc Genetic Clinic Forums Genetics in Pregnancy and Fertility Prenatal Screening Anomalies Nasal bone absent/hypoplastic despite normal NT & negative NIPT, next steps?

Viewing 1 reply thread
  • Author
    Posts
    • #248
      Anonymous
      Moderator

      At my first-trimester morphology scan (12 weeks 6 days), NT measured 2.0mm — within normal range — and all other segments were reported normal. However, the nasal bone was noted as abnormal (absent/hypoplastic). I also had NIPT done, and the result came back negative. I’m now 17 weeks and unsure whether to seek a second opinion/detailed scan, or go ahead with an amniocentesis, which I’m quite anxious about. Would appreciate insight from anyone who’s been through something similar or has medical knowledge on how much weight this finding carries given the negative NIPT.

    • #249
      Sana Fathima K S
      Keymaster

      At 17 weeks, a non-visualized retronasal triangle can imply one of the following, and distinguishing between them requires careful evaluation:

      Technical/positional limitation: fetal position, maternal body habitus, or scanning angle can prevent clear visualization even when anatomy is normal. This is the most common reason and is not itself concerning.
      Possible cleft lip/palate: since the retronasal triangle view is used specifically to screen for facial clefts, non-visualization warrants a dedicated, detailed facial and palate assessment.
      Association with chromosomal anomalies: in some studies, an absent retronasal triangle has been linked to a higher likelihood of Trisomy 21 and other aneuploidies, particularly when seen alongside other soft or hard markers.

      What it implies for the fetus:

      It does not, by itself, confirm a diagnosis of cleft lip/palate or a chromosomal condition.
      It is a prompt for further evaluation, not a conclusion.

      This is a good example of why isolated findings should never be interpreted in isolation from the fetus’s full scan and screening history. The clinical significance depends entirely on:

      Whether it’s an isolated finding or accompanied by other markers/structural findings
      The mother’s background risk (age, prior screening results)
      Whether a repeat scan can achieve visualization

      Limitations:

      *Non-visualization at 17 weeks is later than the ideal window (11–14 weeks) for this specific marker, so its predictive value at this gestation is less standardized in literature compared to first-trimester assessment.
      *A single research-based association does not equal individual diagnostic certainty — this is why follow-up imaging and, where indicated, genetic counseling matter more than the marker in isolation.

      During first-trimester screening, the fetal nasal bone is assessed as a “soft marker” — a physical feature that, when absent or underdeveloped (hypoplastic), is statistically associated with a higher chance of certain chromosomal conditions, most notably Trisomy 21 (Down syndrome). It’s also occasionally associated with some structural or skeletal conditions, though far less commonly.

      A soft marker is not a diagnosis on its own. Many babies with an absent or hypoplastic nasal bone turn out to be chromosomally and structurally completely normal. The finding adjusts a risk estimate usually alongside other markers like NT, blood markers, and maternal age, rather than confirming anything by itself.

      Hypoplastic means underdeveloped or smaller than expected for the gestational age. This is different from “absent,” where no nasal bone is visualized at all. Both are grouped together as abnormal findings in many reports, but they’re technically distinct: hypoplastic means the bone is there but under-measured; absent means it isn’t seen.

      NT of 2.0mm at 12 weeks 6 days is well within the normal range (the cutoff is typically under 2.5–3.0mm depending on CRL at this gestational age). A normal NT lowers overall concern.
      NIPT (non-invasive prenatal testing) analyzes cell-free fetal DNA in maternal blood and has very high sensitivity for Trisomy 21, and high sensitivity for Trisomy 18 and 13. A negative NIPT result substantially lowers the likelihood of these conditions, even when an isolated soft marker like nasal bone hypoplasia is present.

      It’s worth understanding that NIPT is a screening test, not a diagnostic one: it estimates probability rather than confirming or ruling out a condition with certainty, and it doesn’t screen for every possible genetic or chromosomal condition. But for the specific conditions nasal bone hypoplasia is most associated with, a negative NIPT is meaningfully reassuring.

      Get a detailed anomaly/Level II scan with a maternal-fetal medicine (MFM) specialist, who can directly reassess the nasal bone and check for any other associated structural findings.
      Discuss the combined picture- NT, NIPT result, and nasal bone finding with a genetic counselor, who can walk you through an individualized, updated risk assessment rather than a general statistic.
      Amniocentesis is a diagnostic option that gives a definitive answer, but given if normal NT and negative NIPT, it is not automatically necessary. The decision is a personal one best made after the detailed scan and counseling – not something you need to decide right away out of fear.

Viewing 1 reply thread
  • You must be logged in to reply to this topic.